VVZ API is not affiliated with ETH Zurich. Data might be outdated or incorrect. Please view the official ETHZ Vorlesungsverzeichnis for binding information.

551-1711-00L 6 Credits BSC D-BIOL

Translational Medicine and Bio-Entrepreneurship

Number of participants limited to 30 The block course will only take place with a minimum of 10 participants. The enrolment is done by the D-BIOL study administration. General safety regulations for all block courses: -Whenever possible the distance rules have to be respected -All students have to wear masks throughout the course (keep reserve masks ready) -The installation and activation of the Swiss Covid-App is highly encouraged -Any additional rules for individual courses have to be respected -Students showing any COVID-19 symptoms are not allowed to enter ETH buildings and have to inform the course responsible
VVZ CR n/a

Last Updated: 2026-02-05 15:36:22

Abstract

The course gives students a look at the entire drug development process from bench to bedside. ETH and UZH alumni from the pharma, biotech, medtech, digital health and venture capital industry will discuss how intellectual property, regulatory and financial aspects shape this process. Student teams will develop their own business idea and pitch it to a group of entrepreneurs and investors.

Objective

Students know the basis of the drug development process, the basis of patenting and what is required to the start a life science company. The can develop a business idea and a rough financial plan and they can it to a panel of experts.

General Information

Language
English
Levels
BSC
Frequency
Yearly recurring

Examination

Type
graded semester performance

Course Components

Type Title Time & Place Hours
lecture with exercise Translational Medicine and Bio-Entrepreneurship
Permission from lecturers required for all students. Block course in the 1st quarter of the autumn semester Place: Bio-Technopark Schlieren
No time listed 100 h semesterly

Offered In